Charles Schwab Investment Management »

Eiger Biopharmaceuticals shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Eiger Biopharmaceuticals shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Eiger Biopharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eiger Biopharmaceuticals held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eiger Biopharmaceuticals by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.5k 33k 0.22
2023-09-30 $10k 33k 0.31
2023-06-30 $24k 33k 0.70
2023-03-31 $86k 96k 0.90
2022-12-31 $133k 112k 1.18
2022-09-30 $818k 109k 7.54
2022-06-30 $671k 107k 6.30
2022-03-31 $737k 89k 8.31
2021-12-31 $451k 87k 5.20
2021-09-30 $580k 87k 6.69
2021-06-30 $708k 83k 8.53
2021-03-31 $681k 77k 8.85
2020-12-31 $912k 74k 12.29
2020-09-30 $549k 67k 8.15
2020-06-30 $593k 62k 9.61
2020-03-31 $408k 60k 6.81
2019-12-31 $906k 61k 14.90
2019-09-30 $547k 53k 10.25
2019-06-30 $566k 53k 10.61